PLEC and colorectal carcinoma: Notably, increased plectin expression was observed in 38.7% of patients diagnosed with AC, while this percentage increased to 48% in patients with MAC and exceeded 80% in those with SRCC, suggesting that plectin expression may serve as a prognostic indicator of CRC malignancy.